Singh R - Search Results

1

IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model.

Yu EM, Cho E, Singh R, Kim SH, Han C, Han S, Lee DG, Kim YH, Kwon BS, Choi BK. Yu EM, et al. Among authors: singh r. Cells. 2021 Aug 7;10(8):2018. doi: 10.3390/cells10082018. Cells. 2021. PMID: 34440787 Free PMC article.

2

Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression.

Han C, Sim SJ, Kim SH, Singh R, Hwang S, Kim YI, Park SH, Kim KH, Lee DG, Oh HS, Lee S, Kim YH, Choi BK, Kwon BS. Han C, et al. Among authors: singh r. Nat Commun. 2018 Feb 1;9(1):468. doi: 10.1038/s41467-018-02912-x. Nat Commun. 2018. PMID: 29391449 Free PMC article.

3

The hyaluronic acid-rich node and duct system is a structure organized for innate immunity and mediates the local inflammation.

Choi BK, Hwang SH, Kim YI, Singh R, Kwon BS. Choi BK, et al. Among authors: singh r. Cytokine. 2019 Jan;113:74-82. doi: 10.1016/j.cyto.2018.06.011. Epub 2018 Jun 12. Cytokine. 2019. PMID: 29907431 Free article.

4

Siglec1-expressing subcapsular sinus macrophages provide soil for melanoma lymph node metastasis.

Singh R, Choi BK. Singh R, et al. Elife. 2019 Dec 24;8:e48916. doi: 10.7554/eLife.48916. Elife. 2019. PMID: 31872800 Free PMC article.

5

Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8⁺ T cell responses.

Kim SH, Singh R, Han C, Cho E, Kim YI, Lee DG, Kim YH, Kim SS, Shin DH, You HJ, Lee HW, Kwon BS, Choi BK. Kim SH, et al. Among authors: singh r. Cell Mol Immunol. 2021 Aug;18(8):1956-1968. doi: 10.1038/s41423-020-00533-3. Epub 2020 Aug 31. Cell Mol Immunol. 2021. PMID: 32868911 Free PMC article.

6

A Transient Transfection-based Cell Adhesion Assay with 293T Cells.

Singh R, Choi BK. Singh R, et al. Bio Protoc. 2021 Jan 5;11(1):e3878. doi: 10.21769/BioProtoc.3878. eCollection 2021 Jan 5. Bio Protoc. 2021. PMID: 33732766 Free PMC article.

7

4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8⁺ T cell.

Cho E, Singh R, Han C, Kim SH, Kim KH, Park BM, Shin DH, Han S, Kim YH, Kwon BS, Nam KT, Choi BK. Cho E, et al. Among authors: singh r. Cell Mol Immunol. 2023 Sep;20(9):1077-1080. doi: 10.1038/s41423-023-01056-3. Epub 2023 Jun 26. Cell Mol Immunol. 2023. PMID: 37365325 Free PMC article. No abstract available.

8

Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8⁺ T Cell Responses.

Cho E, Han S, Eom HS, Lee SJ, Han C, Singh R, Kim SH, Park BM, Kim BG, Kim YH, Kwon BS, Nam KT, Choi BK. Cho E, et al. Among authors: singh r. Int J Mol Sci. 2023 Sep 5;24(18):13672. doi: 10.3390/ijms241813672. Int J Mol Sci. 2023. PMID: 37761976 Free PMC article.

9

4-1BB immunotherapy: advances and hurdles.

Singh R, Kim YH, Lee SJ, Eom HS, Choi BK. Singh R, et al. Exp Mol Med. 2024 Feb;56(1):32-39. doi: 10.1038/s12276-023-01136-4. Epub 2024 Jan 4. Exp Mol Med. 2024. PMID: 38172595 Free PMC article. Review.

10

A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model.

Lee ES, Jeong MS, Singh R, Jung J, Yoon H, Min JK, Kim KH, Hong HJ. Lee ES, et al. Among authors: singh r. Exp Mol Med. 2012 Apr 30;44(4):293-302. doi: 10.3858/emm.2012.44.4.027. Exp Mol Med. 2012. PMID: 22248567 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,561 results

Search Page

Filters